404856006: Emtricitabine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Reverse transcriptase inhibitor\Emtricitabine (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Emtricitabine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Emtricitabine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Emtricitabine (substance)	Is a	Reverse transcriptase inhibitor	true	Inferred relationship	Some
Emtricitabine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Emtricitabine (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Emtricitabine (substance)	Is a	Pyrimidine	true	Inferred relationship	Some
Emtricitabine (substance)	Is a	Transferase inhibitor	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing emtricitabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some
Emtricitabine 10mg/mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing efavirenz and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing emtricitabine and rilpivirine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some	3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Emtricitabine (substance)	Inferred relationship	Some	7
Emtricitabine 10 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing bictegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only efavirenz and emtricitabine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing only emtricitabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Bictegravir and emtricitabine and tenofovir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Efavirenz and emtricitabine and tenofovir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 10 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 10 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine- and rilpivirine- and tenofovir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Emtricitabine (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2148686015	Emtricitabine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2156735019	Emtricitabine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
55321000195111	emtricitabina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808401000172117	emtricitabine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69901000195112	Emtricitabin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
904731000195110	FTC - Emtricitabin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module